elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38594117-4E994F2A-E12F-445C-9E84-2670144B5BE8
Q38594117-4E994F2A-E12F-445C-9E84-2670144B5BE8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38594117-4E994F2A-E12F-445C-9E84-2670144B5BE8
Flibanserin: First Global Approval.
P2860
Q38594117-4E994F2A-E12F-445C-9E84-2670144B5BE8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38594117-4E994F2A-E12F-445C-9E84-2670144B5BE8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
32dd2da5bd6d62bee9d800ff8c63c148c0e7ed28
P2860
Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brain